Role of immunotherapy in gastric cancer with liver metastasis
Bogdan Gafton1,2, Stefan Morarasu3, Gabriel Dimofte4
1Department of Oncology, Regional Institute of Oncology, Iasi 700483, Romania.
Abstract:
Gastric cancer continues to be a significant issue for public health, marked by its widespread occurrence and high mortality rates, even as the incidence of the disease shows a declining trend. The liver is the primary site for metastatic spread, with the peritoneum, lungs, and bones also being common targets. With the advent of biologic treatments and the introduction of immunotherapy for patients with metastatic conditions, the options to treat metastatic gastric cancer have expanded. This diversified therapeutic approach is designed to enhance patient quality of life and prolong survival, showcasing the progress in treatment modalities for individuals with gastric cancer and liver metastases.
Insights
Gastric cancer remains a public health concern with high mortality. New biologic treatments and immunotherapy offer expanded options for metastatic gastric cancer, improving quality of life and survival.
Area of Science:
- Oncology
- Gastroenterology
- Public Health
Background:
- Gastric cancer presents a significant public health challenge due to high mortality rates, despite a declining incidence.
- Liver metastasis is the most common site of spread for gastric cancer, followed by the peritoneum, lungs, and bones.
Discussion:
- The therapeutic landscape for metastatic gastric cancer has evolved with the integration of biologic treatments and immunotherapy.
- These advancements aim to improve patient outcomes, focusing on enhanced quality of life and prolonged survival.
Key Insights:
- Metastatic gastric cancer, particularly with liver involvement, benefits from novel therapeutic strategies.
- Biologic therapies and immunotherapy represent significant progress in managing advanced gastric cancer.
Outlook:
- Continued research into targeted therapies and immunotherapies holds promise for further improving survival and quality of life in patients with metastatic gastric cancer.
- Personalized treatment approaches may optimize outcomes for individuals with gastric cancer and liver metastases.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
04:22Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
